CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 71 enrolled
Drug / intervention
MINI TREK RX 1.20 mm Coronary Dilatation Catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01186198
NCT01186198N/ACompleted
CompareCT.gov

A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter in Stenotic Lesions

Abbott Medical Devices·observational·Posted Aug 23, 2010·Updated Nov 13, 2023

In Brief

An observational study evaluating MINI TREK RX 1.20 mm Coronary Dilatation Catheter for Ischemic Heart Disease and 3 related conditions. Completed, enrolled 71 participants across 4 sites.

Detailed Summary

This is a prospective, single-arm, open-label, multi-center, observational study to assess the acute safety and efficacy of MINI TREK RX 1.20 mm for enlarging coronary luminal diameter during percutaneous coronary intervention (PCI) procedures in subjects with ischemic heart disease due to stenotic lesions.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsIschemic Heart Disease, Coronary Artery Stenosis, Chronic Coronary Total Occlusion, Coronary Bypass Graft Stenosis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedAug 23, 2010
Enrollment StartAug 12, 2010
Primary CompletionDec 30, 2010
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 15.9 years ago

Interventions

MINI TREK RX 1.20 mm Coronary Dilatation Catheterdevice

Enlarging coronary luminal diameter during percutaneous coronary intervention (PCI) procedures in subjects with ischemic heart disease due to stenotic lesions